Washington University School of Medicine

Digital Commons@Becker
Open Access Publications
2015

Novel genetic locus implicated for HIV-1 acquisition with putative
regulatory links to HIV replication and infectivity: A genome-wide
association study
Nancy L. Saccone
Washington University School of Medicine in St. Louis

John P. Rice
Washington University School of Medicine in St. Louis

Laura J. Bierut
Washington University School of Medicine in St. Louis

et al

Follow this and additional works at: https://digitalcommons.wustl.edu/open_access_pubs

Recommended Citation
Saccone, Nancy L.; Rice, John P.; Bierut, Laura J.; and et al, ,"Novel genetic locus implicated for HIV-1
acquisition with putative regulatory links to HIV replication and infectivity: A genome-wide association
study." PLoS One. 10,3. e0118149. (2015).
https://digitalcommons.wustl.edu/open_access_pubs/3782

This Open Access Publication is brought to you for free and open access by Digital Commons@Becker. It has been
accepted for inclusion in Open Access Publications by an authorized administrator of Digital Commons@Becker.
For more information, please contact vanam@wustl.edu.

RESEARCH ARTICLE

Novel Genetic Locus Implicated for HIV-1
Acquisition with Putative Regulatory Links to
HIV Replication and Infectivity: A GenomeWide Association Study
a11111

Eric O. Johnson1*, Dana B. Hancock1, Nathan C. Gaddis1, Joshua L. Levy1, Grier Page1,
Scott P. Novak1, Cristie Glasheen1, Nancy L. Saccone2, John P. Rice2, Michael P. Moreau3,
Kimberly F. Doheny4, Jane M. Romm4, Andrew I. Brooks3, Bradley E. Aouizerat5,6, Laura
J. Bierut2, Alex H. Kral1
1 RTI International, Research Triangle Park, NC, Atlanta, GA, San Francisco, CA, United States of America,
2 Washington University School of Medicine, St. Louis, MO, United States of America, 3 Rutgers University
Cell and DNA Repository (RUCDR), Piscataway, NJ, United States of America, 4 Center for Inherited
Disease Research (CIDR), Johns Hopkins University, Baltimore, MD, United States of America, 5 School of
Nursing, University of California San Francisco, San Francisco, CA, United States of America, 6 Institute for
Human Genetics, University of California San Francisco, San Francisco, CA, United States of America

OPEN ACCESS
Citation: Johnson EO, Hancock DB, Gaddis NC,
Levy JL, Page G, Novak SP, et al. (2015) Novel
Genetic Locus Implicated for HIV-1 Acquisition with
Putative Regulatory Links to HIV Replication and
Infectivity: A Genome-Wide Association Study. PLoS
ONE 10(3): e0118149. doi:10.1371/journal.
pone.0118149
Academic Editor: Weijing He, University of Texas
Health Science Center San Antonio Texas, UNITED
STATES
Received: June 5, 2014
Accepted: January 5, 2015
Published: March 18, 2015
Copyright: © 2015 Johnson et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any
medium, provided the original author and source are
credited.
Data Availability Statement: The UHS cohort
phenotype and genotype data are available through
dbGaP: accession number phs000454.v1.p1.
Detailed analysis results are available in Tables S2
and S3.
Funding: This work was supported by the National
Institute of Drug Abuse (NIDA) grants R01 DA026141
and X01 HG005275: EOJ. Storage and processing of
UHS serum samples for DNA extraction and
genotyping was conducted by the Rutgers University

* ejohnson@rti.org

Abstract
Fifty percent of variability in HIV-1 susceptibility is attributable to host genetics. Thus identifying
genetic associations is essential to understanding pathogenesis of HIV-1 and important for targeting drug development. To date, however, CCR5 remains the only gene conclusively associated with HIV acquisition. To identify novel host genetic determinants of HIV-1 acquisition, we
conducted a genome-wide association study among a high-risk sample of 3,136 injection drug
users (IDUs) from the Urban Health Study (UHS). In addition to being IDUs, HIV- controls were
frequency-matched to cases on environmental exposures to enhance detection of genetic effects. We tested independent replication in the Women’s Interagency HIV Study (N=2,533).
We also examined publicly available gene expression data to link SNPs associated with HIV
acquisition to known mechanisms affecting HIV replication/infectivity. Analysis of the UHS
nominated eight genetic regions for replication testing. SNP rs4878712 in FRMPD1 met multiple testing correction for independent replication (P=1.38x10-4), although the UHS-WIHS
meta-analysis p-value did not reach genome-wide significance (P=4.47x10-7 vs. P<5.0x10-8)
Gene expression analyses provided promising biological support for the protective G allele at
rs4878712 lowering risk of HIV: (1) the G allele was associated with reduced expression of
FBXO10 (r=-0.49, P=6.9x10-5); (2) FBXO10 is a component of the Skp1-Cul1-F-box protein E3
ubiquitin ligase complex that targets Bcl-2 protein for degradation; (3) lower FBXO10 expression was associated with higher BCL2 expression (r=-0.49, P=8x10-5); (4) higher basal levels
of Bcl-2 are known to reduce HIV replication and infectivity in human and animal in vitro studies. These results suggest new potential biological pathways by which host genetics affect
susceptibility to HIV upon exposure for follow-up in subsequent studies.
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Introduction
Susceptibility to acquiring HIV-1 is a heritable trait, with an in vitro study estimating that 50%
is attributable to host genetics.[1,2] However, HIV infection is a gene-by-environment process
requiring exposure. It is likely that multiple HIV exposures are required for infection: 100 incidents of sharing needles with an HIV+ injection drug user (IDU) or 200 incidents of unprotected receptive anal sex with an HIV+ partner being needed, on average, to transmit the virus.
[3–5] Thus, accounting for HIV exposure is critical to studying host genetics of
HIV acquisition.
Five of seven previous genome-wide association studies (GWAS) of HIV acquisition incorporated measurements of HIV exposure (mother-to-child transmission,[6] serodiscordant heterosextual couples,[7] clinic-based recruitment for sexually transmitted infections (STIs),[8]
recruitment of HIV- sex workers,[9] and hemophiliacs with probable exposure[10]), however
the studies’ sample sizes were small (n = 226–1,379).[6–10] The two other GWAS of HIV acquisition achieved the largest samples sizes (n = 1,837 and13,851) but used population-based
controls who were unlikely to have been exposed to HIV-1.[11,12] None of these prior GWAS
identified replicable genes contributing to HIV susceptibility. [1,2,12] Thus, since its discovery
in 1996, a 32-base pair deletion in the CCR5 gene remains the only genetic variant conclusively
associated with HIV acquisition.[12–14] Identifying additional genetic associations with HIV
acquisition is important to understanding the pathogenesis of HIV-1 and providing targets for
medication and vaccine development[1,15] as illustrated by CCR5Δ32 giving rise to an antiretroviral drug inhibiting viral entry (maraviroc).[13,14]
In this study, we conducted a GWAS of HIV-1 acquisition among a high-risk sample of 3,136
IDUs from the Urban Health Study (UHS). In addition to both cases and controls being IDUs,
HIV- controls were frequency-matched to HIV+ cases on a number of exposure risks (e.g., sexual risks)—enhancing detection of genetic contributions to differences in HIV status. We tested
for independent replication in the Women’s Interagency HIV Study (WIHS, N = 2,533) and examined gene expression data to link the replicated novel SNP association with HIV acquisition
to known mechanisms affecting viral replication and infectivity during acute HIV exposure.

Materials and Methods
In this study we conducted discovery genome-wide association analyses in the UHS cohort,
replication testing in the WIHS cohort, and assessment of regulatory potential of replicable
variants using publicly available gene expression data. A summary of this study design is presented in Fig. 1, with detailed discussion following.

Discovery Sample
Study participants were from the UHS, a serial, cross-sectional, sero-epidemiological study of
IDUs in the San Francisco Bay Area from 1986 to 2005.[16,17] Study eligibility criteria included injection of an illicit drug in the past 30 days (verified by signs of venipuncture), ability to
provide informed consent, age 18 or older, and ability to speak English or Spanish. Participants
were interviewed face-to-face regarding key demographics, drug use, and sexual risk behavior.
HIV-1 infection status was determined from serum blood samples using enzyme immunoassay
and Western Blot assay, identifying HIV+ cases as those who had detectable antibodies.[16,17]
The present analysis included self-reported Caucasians (henceforth referred to as European
Americans [EAs]) and African Americans (AAs).
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Fig 1. Overview of Study Design. AA represents African Americans, EA represents European Americans,
and UofC represents University of Chicago.
doi:10.1371/journal.pone.0118149.g001

Genome-wide Genotyping and Imputation
All HIV+ cases in the UHS were genotyped. For every case, two HIV- controls were selected
for genotyping based on frequency-matching with respect to five criteria: self-identified ancestry, self-identified sex, age group, survey year (pre/post antiretroviral therapy availability), and
risk profile that included risky sexual and drug use behaviors (see S1 Methods and S1 Fig.).
Genotyping was conducted on 3,732 samples using the Illumina Omni1-Quad BeadChip on restored genomic (not amplified) DNA samples from serum (see S1 Methods). Following quality
control (QC), there remained 789,322 autosomal genotyped single nucleotide polymorphisms
(SNPs) in 2,017 AAs and 792,340 autosomal genotyped SNPs in 1,142 EAs. Their ancestral
proportions are shown in S2 Fig.
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Genotype imputation of SNPs and insertion/deletion polymorphisms (indels) was used to
expand coverage and increase statistical power.[18] Imputation was conducted in AAs and
EAs, separately, using IMPUTE2[18] with reference to the ALL 1000 Genomes reference panel
[19] (see S1 Methods).

Genome-wide Association Analyses
Imputed SNPs and indels were tested for association with HIV-1 case/control status using logistic regression models stratified by ancestry and adjusted for age, sex, behavioral risk class
(based on latent class analysis), survey year, and the first 10 principal components to minimize
bias due to population stratification (see S1 Methods). The final analysis included 2,004 AAs
(628 cases; 1,376 controls) and 1,132 EAs (327 cases; 805 controls) who passed QC and had
complete covariate data.
In addition to the ancestral-specific GWAS, we conducted a multi-ancestral meta-analysis
to enhance statistical power with a larger sample size. [20,21] The ancestral-specific GWAS results were combined in a fixed-effects sample size-weighted meta-analysis, as done in prior
multi-ancestral meta-analyses[22,23], using the METAL program.[24] Meta-analysis results
with P<5x10-8 were considered statistically significant.[25]

Replication Study Participants and Analyses
Top GWAS meta-analysis results were tested for independent replication in AAs and EAs
from the WIHS: the largest longitudinal cohort study of HIV+ and high-risk HIV- women.[26]
Similarly to prior GWAS,[27]chromosomal regions from the discovery analysis were selected
for replication beyond those with genome-wide significant SNPs. Promising regions / peaks for
“deeper” replication testing were selected based imputed SNP/indel associations with
P<1x10-6 or having the top genotyped SNP association (P = 1x10-5), following previously successful studies.[27,28] Each region was defined by 3MB spanning the top associated SNP, given
that GWAS signals can reflect synthetic associations as far as 2.5MB away.[29,30] Thus, 692
SNPs and indels with P<1x10-3 across the selected regions were tested for replication in
WIHS.[28]
All WIHS participants who consented were genotyped on the Illumina Omni2.5 BeadChip
using blood as the DNA source. However, only the genotyped SNPs from the 8 selected genomic regions were provided to conduct imputation to the 692 follow-up SNPs and indels that
were used for replication testing in the current study. The UHS QC and imputation procedures
were repeated for the WIHS participants and their genotyped SNPs from the selected regions.
The final analysis data set included 1,852 AAs (1,395 cases; 457 controls) and 681 EAs (513
cases; 168 controls). Imputed SNPs and indels were tested for association with HIV-1 acquisition in logistic regression models adjusted for age, sexual identity (heterosexual, bisexual, lesbian/gay, other), ever use of injected and non-injected drugs, ever had sex with HIV+ male,
number of lifetime sexually transmitted diseases (other than HIV and chlamydia), ever had
chlamydia, number of sex partners, collection site, wave of recruitment, and 10 principal components. The P value threshold for statistically significant replication was 3.21x10-4, corresponding to correction for 156 independent tests across the 692 selected SNPs and indels from
8 top gene regions (see S1 Methods).[31,32]
In sum, genome-wide significance threshold was set at P< 5x10-8 in the UHS cohort. Given
prior successful identification of replicable SNP—disease associations from among signals that
were not genome-wide significant in discovery, lower thresholds were used to select regions for
follow-up in the WIHS (imputed variants with P<1x10-6 and the top genotyped SNP association with P = 1x10-5). Within the follow-up regions, variants that had a discovery P<1x10-3
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within 3MB of the top variant were selected, a total of 692. Taking into account linkage disequilibrium among the 692 follow-up SNPs this constituted 156 independent tests for replication
(P<3.21x10-4).

Bioinformatic and Expression Analyses
We evaluated the regulatory potential of replicated findings using the HaploReg v2 database,
[33] the University of Chicago expression quantitative trait loci (eQTL) browser, and publically
available Montgomery et al.[34] expression array and RNA sequencing data (see S1 Methods).
We assessed replication of gene expression findings using Genevar [35]and publically available
expression array data from the MuTHER resource[36] and Stranger et al.[37] (see
S1 Methods).

Ethics Statement
The Institutional Review Boards at RTI International and the University of California, San
Francisco approved all study procedures for the UHS. The Institutional Review Board at the
University of California, San Francisco approved all study procedures for WIHS. All participants in both studies provided written informed consent.

Results
GWAS and Replication Cohorts
GWAS and replication testing were conducted using the UHS cohort of high-risk IDUs and
the WIHS cohort of high-risk women, respectively (Table 1). By design (S1 Methods), UHS
HIV+ cases and HIV- controls have parallel profiles of HIV exposure risk behaviors that enhance detection of genetic associations with HIV acquisition (S1 Table). Although we did not
purposefully match HIV+ cases to HIV- controls in the WIHS, WIHS controls are very similar
to cases on most HIV exposure risk behaviors and at much higher risk than the general U.S.
population due to matched venue/community-based recruitment [26] (S1 Table).

Discovery GWAS
The ancestry-specific GWAS analyses revealed no genome-wide significant associations
(P<5x10-8, S3 and S4 Figs.). To identify SNP/indel associations with HIV acquisition that are
shared across the ancestral groups, we conducted a GWAS meta-analysis of AA and EA IDUs
in the UHS cohort based on 8 million imputed SNP and indel genotypes (MAF > 0.5%). The
resulting quantile-quantile plot showed some deviation from expectation among top SNP/
indel associations but no genomic inflation (λgc = 1.008; S5 Fig.). We identified one genomewide significant association on chromosome 19 upstream of the CD33 gene (rs3987765 metaanalysis p = 4.38x10-8) and 6 other regions of interest (P<1x10-6). An eighth region on
chromosome 9 had the top genotyped SNP association (P = 1.02x10-5). The 692 SNPs and
indels selected for replication testing from the 8 regions are highlighted in Fig. 2. Their regional
association plots from the GWAS meta-analysis are shown in S6 and S7 Figs.
In addition to the top 8 gene regions, we used the UHS meta-analysis results to look-up 24
candidate SNPs that were previously implicated for their suggestive association with HIV-1 acquisition as reviewed by An and Winkler [38] or McLaren et al. [6–9,11,12](S2 Table). None of
these previously suggested candidate SNPs had meta-analysis P<0.05 in this study.
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Table 1. Characteristics of participants in the Urban Health Study and the Women’s Interagency HIV Study.
Urban Health Study—Discovery Cohort
Characteristic

N = 3,136

Women’s Interagency HIV Study—Replication Cohort
%

Characteristic

HIV Status

N = 2,533

%

HIV Status

Negative

955

30.4

Negative

1,908

75.3

Positive

2,181

69.6

Positive

625

24.7

Male

781

24.9

Male

2,533

100.0

Female

2,355

75.1

Female

0

0.0

Sex

Sex

Ancestry

Ancestry

European American

2,004

63.9

African American

1,852

73.1

African American

1,132

36.1

European American

681

26.9

1986–1994

1,763

56.2

1994–1995

1,755

69.3

1995–2002

1,373

43.8

2001–2002

778

30.7

Year Participated

Recruitment Wave

doi:10.1371/journal.pone.0118149.t001

Replication Tests in WIHS
The top replication SNP from each of the follow-up regions is presented in Table 2. Results for
all tested SNPs and indels are presented in S3 Table. An intronic SNP, rs4878712, in the FERM
And PDZ Domain Containing 1 (FRMPD1) gene on chromosome 9 replicated at P = 1.38x104
, which surpassed our threshold for multiple testing correction. Its meta-analysis P-value
across UHS and WIHS was P = 4.47x10-7 with the G allele consistently showing a protective

Fig 2. Manhattan plot showing the meta-analysis results of approximately 8 million SNPs and indels tested for association with HIV-1 acquisition
in 2,004 African Americans and 1,132 European Americans from the Urban Health Study. The–log10 (P value) is plotted by chromosomal position of
SNPs (shown as circles) and indels (shown as triangles). The SNPs and indels selected for replication testing from 8 gene regions are highlighted in red. The
gene region above the solid grey line (P<5x10-8) exceeded the threshold for genome-wide statistical significance. In addition, the 6 gene regions above the
dashed black line (P<1x10-6) and the region around the top genotyped SNP (P = 1x10-5 on chromosome 9) were selected for replication testing.
doi:10.1371/journal.pone.0118149.g002
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Table 2. Replication meta-analysis results of SNP associations with HIV acquisition in African Americans and European Americans from the
Women’s Interagency HIV Study. Results are presented for the SNP/indel with the best evidence for replication in each GWAS-implicated chromosomal
region. These SNPs/indels were selected for replication testing based on having GWAS meta-analysis P<1x10-3 in each implicated region. SNPs/indels
are sorted by their WIHS meta-analysis P value. Statistically signiﬁcant replication was declared where WIHS meta-analysis P<3.21x10-4 based on
correction for multiple testing (shown in bold).
Chr: SNP
Position
SNP
(coded allele) (NCBI build Type
37)

Gene /
Nearby
genes

UHS—discovery
AAs (N = 2,004)
CAF P

OR
(95%
CI)

WIHS—replication

EAs (N = 1,132)
CAF P

OR
(95%
CI)

UHS
AAs (N = 1,852)
metaOR
analysis CAF P
(95%
P
CI)

EAs (N = 681)
CAF P

OR
(95%
CI)

WIHS
metaanalysis
P

UHS and
WIHS
metaanalysis
P

0.92
0.54 0.13 0.80
7.78x10-4 0.31 4.14x10-4 0.72
1.38x10– 4.47x10-7
(0.61–
(0.76–
(0.59– 4
0.87)
1.12)
1.07)

9p13.2:
rs4878712
(Gb) **

37,654,257

Intronic

FRMPD1 0.31 3.62x10-4 0.76
0.56 0.40
(0.65–
0.88)

9p24.1:
rs16925298
(G) ***

7,081,674

Intronic

KDM4C

0.06 0.076

1.30
5.96x10-4 0.06 4.60x10-4 2.00
0.04 0.63 1.22
0.02 8.03x10-4 2.63
1.18x10-3 2.34x10-6
(1.49–
(1.37–
(0.97–
(0.55–
4.76)
3.03)
1.72)
2.70)

Intronic

HLADQA1

0.28 0.043

0.85
0.24 3.12x10-3 0.70
6.94x10-4 0.15 2.91x10-3 1.47
0.15 0.30 1.25
2.08x10-3 0.64
(0.72–
(0.55–
(1.15–
(0.81–
0.99)
0.89)
1.92)
1.92)

6p21.32:
32,606,042
rs9272490 (A)
5q31.2:
rs13154187
(C)

137,768,385 Intronic

KDM3B

0.21 0.023
0.05 7.47x10-3 1.51
(1.12–
2.05)

19q13.33:
rs112231249
(G)

50,713,024

MYH14

0.13 4.62x10-3 1.39
0.03 5.99x10-3 2.13
9.03x10-5 0.13 0.33
(1.10–
(1.25–
1.72)
3.70)

1q42.3:
rs10910535
(T) **

235,096,551 Intergenic IRF2BP2 0.14 0.15
/
TOMM20

Intronic

SEZ6L

26,666,246
22q12.1:
rs137181 (Ga)
***

Intronic

1p36.13: chr1: 19,357,344
19357344:D
(A)

Intergenic IFFO2 /
UBR4

1.30
0.24 0.44 1.15
4.51x10-4 0.06 3.39x10-3 1.89
3.64x10-3 5.29x10-6
(1.23–
(1.04–
(0.81–
2.86)
1.61)
1.61)
1.15
0.03 0.043 2.70
0.059
(0.87–
(1.03–
1.49)
7.14)

3.01x10-5

0.92
0.26 0.042 0.71
0.10
(0.71–
(0.52–
1.18)
0.99)

0.17

1.18
4.91x10-4 0.40 0.18
(0.98–
1.42)

1.12
0.51 0.37 1.14
0.11
(0.95–
(0.85–
1.34)
1.54)

2.52x10-4

0.18 2.50x10-4 0.69
0.34 5.20x10-4 0.69
5.37x10-7 0.18 0.46
(0.57–
(0.56–
0.85)
0.85)

1.09
0.38 0.094 1.30
0.13
(0.86–
(0.95–
1.37)
1.75)

6.47x10-3

8.79x10-4 0.13 0.49
1.18
0.28 2.86x10-4 1.52
(1.21–
(0.94–
1.89)
1.45)

0.39 2.14x10-3 1.24
0.50 0.086
(1.08–
1.43)

CI, conﬁdence interval; CAF, coded allele frequency; OR, odds ratio
a
G is the minor allele for rs137181 in UHS and WIHS AAs, the equi-frequent allele in UHS EAs, and the major allele for WIHS EAs.
b

G is the minor allele for rs4878712 in UHS and WIHS AAs but the major allele in UHS and WIHS EAs.

Asterisks indicate that the SNP was genotyped in WIHS only (**) or in both UHS and WIHS (***). Otherwise, SNPs were imputed in both study cohorts.
doi:10.1371/journal.pone.0118149.t002

effect for HIV acquisition. The G allele had a lower frequency in cases vs. controls for both ancestry groups in UHS and WIHS: 0.27 vs. 0.33 in UHS AAs, 0.54 vs. 0.56 in UHS EAs, 0.30 vs.
0.35 in WIHS AAs, and 0.52 vs. 0.57 in WIHS EAs. The rs4878712 SNP is located approximately 600kb away from the SNP with the smallest meta-analysis P-value from the discovery
analysis of the UHS, rs1329568 (S6H and S7H Figs.). D’ values between rs4878712 and
rs1329568 are high in EUR (1.0), but of modest statistical significance, and limited in AFR
(0.22) (S8A and S9A Figs.). Their r2 values that suggest no correlation are likely constrained by
dissimilar allele frequencies [39] (S8B and S9B Figs.). However, examining the haplotypes of
the top discovery and top replication SNPs shows the strongest protective effect in the GG haplotype relative to the high risk AT haplotype, with a meta-analysis P-value (P = 5.44x10-8) nearly an order of magnitude smaller than the meta-analysis of rs4878712 alone. These results
suggest that these SNPs may be tapping into a shared haplotype with a causal variant, representing the same signal. See S4 Table for rs4878712-rs1329568 haplotype analyses by cohort,
ancestry, and overall.
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Two additional chromosomal regions harbored SNPs with nominal evidence of replication
(P3.64x10-3): rs13154187 in the Lysine (K)-Specific Demethylase 3B (KDM3B) gene on chromosome 5 and rs16925298 in the Lysine (K)-Specific Demethylase 4C (KDM4C) gene on chromosome 9. Although Major Histocompatibility Complex, Class II, DQ Alpha 1 (HLA-DQA1)
SNPs on chromosome 6 also had nominal associations with HIV status in WIHS, opposing directions of association were observed between UHS and WIHS (Table 2). The genome-wide
significant finding on chromosome 19 observed in UHS was not replicated in WIHS:
rs3987765 replication p = 0.47.

Bioinformatics and Expression Analyses of FRMPD1 and HIV-1
We evaluated the FRMPD1 SNP rs4878712 for its regulatory potential via the University of
Chicago eQTL, which identified this SNP as an eQTL for the F-box Protein 10 (FBXO10) gene
in lymphoblastoid cells lines (LCL). Our further examination of the available Montgomery
et al. RNA-sequencing data,[34] showed that the minor G allele, which reduced risk of HIV acquisition, significantly reduced exon 11 expression in FBXO10 (r = -0.49, P = 6.9 x 10-5). No
other RNAseq data reporting results for FBXO10 and rs4878712 in LCL were publically available. Examining publically available micro-array gene expression data, we observed an independent corroborating inverse association between rs4878712 and FBXO10 in LCL for the
gene expression probe ILM_2089616 located in exons 9/10 (β = -0.028, P = 0.0176; MuTHER
resource[35,36]). However, no association was seen between rs4878712 and the FBXO10 probe
ILM_1716952, which is located farther away in exons 4/5, in two independent datasets (the
MuTHER resource P = 0.962; Stranger et al. 2012[37]; P = 0.567). The ILM_2089616 probe
with suggestive corroborating evidence was not available in the Stranger et al. 2012 data. Finding evidence of reduced expression of FBXO10 associated with the rs4878712-G allele from
two datasets with probes near the 3’ end of the gene but not for a probe toward the 5’ end of
the gene may reflect differences in quality of the expression signal from the different probes or
the probes tagging different gene transcripts (S10 Fig.).
The observed reduced expression of FBXO10 associated with the G allele of rs4878712 may
have biological links to risk of HIV acquisition. FBXO10 is a component of a Skp1-Cul1-Fbox protein (SCF) E3 ubiquitin ligase complex that directly targets Bcl-2 protein for degradation.[40] There is interplay between Bcl-2 and HIV in a number of ways over the course of
infection,[41] but in the acute phase, higher levels of Bcl-2 are protective in vitro and in animal
models.[42,43] Thus, lower levels of FBXO10 expression could be expected to lead to less tagging of Bcl-2 protein for degradation, higher levels of Bcl-2, and greater protection against
HIV. Consistent with this possibility, we observed an inverse association between expression of
FBXO10 and BCL2 (r = -0.49, P = 8 x10-5; Fig. 3).

Discussion
This study identified and replicated a promising novel association between rs4878712, located
in the FRMPD1 gene, and HIV acquisition. FRMPD1 has not been previously associated with
HIV and its function is unclear, though it may play a role in subcellular location of activator of
G-protein signaling 3 (AGS3)[44] and interact with Leu-Gly-Asn repeat-enriched protein
(LGN).[45] Analysis of gene expression data revealed that rs4878712 is an exon-level eQTL for
the FBXO10 gene and that FBXO10 expression is inversely associated with BCL2 expression:
the HIV-protective G allele reducing FBXO10 expression, and reduced FBXO10 expression
being associated with increased expression of BCL2 in healthy lymphoblastoid cells. FBXO10 is
part of an SCF E3 ubiquitin ligase that targets Bcl-2 protein for degradation[40] and higher
basal level of Bcl-2 protein is linked to reduced viral replication and infectivity of HIV in the
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Fig 3. Correlation between FBXO10 and BCL2 gene expression. Individual data points for 60 HapMap
CEU samples are presented as blue dots, and the linear trend line is shown in black. Microarray data
generated and made publically available by Montgomery et al. [34].
doi:10.1371/journal.pone.0118149.g003

acute phase, potentially distinguishing those who will have an acute infection and those who
will develop a persistent one.[42] We hypothesize that Bcl-2 upregulation may be assisted by
the putative effect of the rs4878712-G allele on reducing FBXO10 expression, providing less
SCF E3 ubiquitin ligase to tag Bcl-2 for degradation and higher basal BCL2 expression. Our
combination of gene expression evidence and extant literature is consistent with a plausible
mechanism linking rs4878712 to acute response to HIV exposure (Fig. 4).
The SNP rs4878712 could be linked with HIV in at least two other ways. First, a recent
study of FBXO10 as a potential oncogene found that manipulation of Lens epithelium-derived
growth factor/p75 (LEDGF/p75) protein was positively correlated with FBXO10 expression in
a cellular oxidase stress model. LEDGF/p75 is a key co-factor tethering HIV DNA to host
DNA and directing viral DNA integration.[46] Depletion or knockdown of LEDGF/p75 substantially reduces infectivity of the virus.[47] If lower FBXO10 expression reduces available
LEDGF/p75, then it may contribute to protection from HIV infection. Second, ENCODE data
identifies rs4878712 as modifying the regulatory motif PRDM1_disc1, suggesting that
rs4878712 may alter the transcription binding site for PRDI-BF1 on the FRMPD1 gene. Of
note, the PRDI-BF1 (or BLIMP-1) protein is a transcriptional repressor broadly implicated in
T-cell inhibition during HIV infection.[48]

Fig 4. Putative pathway between FRMPD1 SNP rs4878712 and reduced risk of HIV acquisition
through FBXO10 and BCL2/Bcl-2.
doi:10.1371/journal.pone.0118149.g004
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Nominally replicated SNP association signals in the KDM3B and KDM4C genes are also of
potential interest. Both genes function to demethylate Lysine 9 at histone 3 (H3K9).[49] Methylation state of this histone tail site plays a role in silencing/activating HIV transcription at the
5’ end of the long terminal repeats: H3K9 sites are highly methylated in silenced latent HIV,
generating a reservoir of virus that is unaffected by the immune system and highly active antiretroviral therapy (HAART).[50] Reactivation of HIV transcription is accompanied by a drop
in trimethylation of H3K9,[50] and KDM4C is known to convert trimethylated to dimethylated
histone residues.[49]
This study’s novel findings may have been enabled by its unique design. Unlike prior
GWAS of HIV acquisition, the discovery UHS data set matched HIV- IDU controls to the HIV
+ IDU cases on several HIV risk behaviors (see S1 Methods and S1 Fig.), largely equating measurable risk of HIV exposure within this high-risk cohort (S1 Table) and, in theory, improving
our statistical power to detect genetic associations with HIV acquisition.
Five prior GWAS of HIV acquisition used other measures of HIV exposure to define HIVcontrols including: mother-to-child transmission,[6] recruitment from an STI clinic,[8] recruitment of HIV- sex workers,[9] and hemophiliacs with probable exposure.[10] However,
these studies did not further equalize degree of HIV exposure between cases and controls. An
exception is Lingappa et al’s study of serodiscordant heterosexual couples,[7] wherein nonseroconverting couples where matched to seroconverting couples on baseline HIV exposure
risk based on unprotected sex with HIV+ partner, male uninfected partner uncircumcised, uninfected partner age <25 years, and infected partner plasma viral RNA level. Further, controls
for HIV acquisition analyses were selected based on two levels of high HIV exposure scores.
The sample sizes for these 5 GWAS were small, ranging from 226 to 1,379 participants. Two
other GWAS of HIV acquisition used population controls.[11,12] Although the most recent
GWAS used the largest sample size to date (N = 13,851),[12] the vast majority of population
controls are unlikely to have been exposed to HIV. Without exposure to the virus, such controls may be minimally informative for studying host genetics of HIV-1 acquisition, suggesting
that even larger sample sizes will be required for sufficient statistical power. We assessed top
GWAS signals and candidate genes reported in the prior GWAS,[6–12] but did not find any
other evidence of replicable association between the previously implicated variants and HIV
acquisition in the UHS cohort (P>0.05, see S2 Table). Prior suggestive findings may not be
truly associated; we may remain underpowered to adequately test these associations; and/or
the difference in types (sexual vs. drug injection) or degree of HIV exposure across studies may
limit the field’s ability to replicate findings.
Although this study has several strengths, there are limitations. First, and most notably, the
SNPs with the best evidence for replication were not the top SNP associations from the discovery analysis. For replication, we took all SNPs with P<1x10-3 that were within 3MB of the top
discovery SNP for each signal based on the recognition that variants with the top statistical association signals and the underlying true causal variants may not be the same.[29,30] Although
this is a broad replication strategy and the meta-analysis P value does not meet genome-wide
significance (P = 4.47x10-7 vs. P<5.0x10-8), we applied appropriate multiple testing correction
and identified a SNP association that surpassed the significance threshold for replication. Haplotype analyses of the top replication SNP (rs4878712) and the discovery SNP on chromosome
9 (rs1329568) suggested a stronger association when considering the paired protective alleles
(meta-analysis P = 5.44x10-8) than rs4878712 alone (meta-analysis P = 4.47x10-7), which may
indicate a shared haplotype with a causal variant representing a single signal. Second, although
different types of HIV exposure were present in both the discovery and replication cohorts, differences in the predominate modes of HIV exposure between the UHS IDUs and the all female
WIHS cohort would tend to emphasize genetic factors that are common across modes of
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exposure and could have limited our ability to replicate findings. Another limitation is that the
gene expression analyses in this study are limited by the publically available data. The Montgomery et al.[34] RNAseq data provided the strongest evidence of rs4878712 as an eQTL for
FBXO10, particularly for exon 11. The MuTHER resource data[36] provided corroborating evidence of reduced FBXO10 expression associated with the rs4878712 G allele for an expression
array probe located near exon 11. However, a more distal probe near exons 4/5 did not show
such an association. Additionally, the available gene expression data are from subjects of European ancestry. Analysis of African American samples in the future would be of significant
value. It will also be of value for future studies to move beyond the in vitro and animal model
studies to test the putative linkage of BCL2/Bcl-2 to HIV infectivity in humans. Nonetheless,
the gene expression analyses presented in this study suggest a novel and biologically plausible
role for the identified SNP (rs4878712) in HIV acquisition.
In this study we identified and independently replicated a novel association between a variant in the FRMPD1 gene and HIV acquisition. The magnitude of the replicable association between this newly implicated SNP (rs4878712) and HIV acquisition is modest. Nonetheless, the
potential pathway we present (rs4878712 to FBXO10 and FBXO10 to BCL2/Bcl-2) has good biological plausibility, given the observed protection against viral replication and lower level of
infectivity in vitro due to basal level of Bcl-2. This or other pathways associated with rs4878712
could be important mechanisms contributing to the variability in susceptibility to HIV infection upon exposure and provide new targets for medication development.
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